K233100

Substantially Equivalent

QIAstat-Dx® Respiratory Panel Plus

Applicant: QIAGEN GmbH
Product code: QOF
Advisory panel: Microbiology
Date received: 2023-09-26
Decision date: 2024-05-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hilden, DE

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.